ZIOP - Ziopharm Oncology, Inc.
Previous close
0.8657
0 0%
Share volume: 0
Last Updated: Wed 26 Jan 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.87
0.00
0.00%
Summary score
38%
Profitability
43%
Dept financing
4%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-64.54%
Return on assets
-13.62%
Return on sales
0%
Return on invested capital
1.22%
Total debt ratio
40.09%
Debt ratio change over timeo
-0.86%
Current Ratio
7.25%
Quick Ratio
0%
Cash Position Ratio
5.85%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.96%
Return on assets
-11.44%
Return on sales
0%
Return on invested capital
353.91%
Total debt ratio
10.51%
Debt ratio change over timeo
-0.96%
Current Ratio
10.11%
Quick Ratio
0%
Cash Position Ratio
8.39%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.38%
Return on assets
-10.24%
Return on sales
0%
Return on invested capital
216.01%
Total debt ratio
10.05%
Debt ratio change over time
-0.95%
Current Ratio
10.12%
Quick Ratio
0%
Cash Position Ratio
8.97%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.87%
Return on assets
-105.45%
Return on sales
0%
Return on invested capital
-173.99%
Total debt ratio
-86.36%
Debt ratio change over time
-0.86%
Current Ratio
3.04%
Quick Ratio
0%
Cash Position Ratio
2.28%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ZIOP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -64.54% | 0% | 0% | 29.06% |
| Return on assets | -13.62% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 1.22% | 0% | 0% | 47.78% |
| Profitability | 26% | 0% | 25% | 50% |
| Total debt ratio | 40.09% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.86% | 0% | 0% | 19.02% |
| Dept financing | 5% | 0% | 0% | 50% |
| Current Ratio | 10.11% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 8.39% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 55% |
| Short-term ratios | ZIOP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -26.96% | 0% | 0% | -16.12% |
| Return on assets | -11.44% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 353.91% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 7% |
| Total debt ratio | 10.51% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.96% | 0% | 0% | 0.09% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 10.11% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 8.39% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 57% |